External Publication
Visit Post

Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In Treatment

NDTV.com February 10, 2026
Source
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer...

Discussion in the ATmosphere

Loading comments...